Every time we talk about vaccines, a question comes to mind: when will a COVID-19 vaccine be ready?
In reaction to this question, the Union’s Minister of Health and Family Welfare, Dr. Harsh Vardhan, told the Hindustan Times: “COVID-19 vaccine trials are accelerating worldwide. Testing of vaccines manufactured in India is expected to be completed until the end. this year”
Covaxin, the first coronavirus vaccine in India evolved through Bharat Biotech evolved through Bharat BioTech, the Indian Medical Research Council (ICMR) and the National Institute of Virology (NIV). The clinical trial to verify the protection of the possible COVID-19 vaccine dates back two weeks. “It may be available until the end of the year,” Vardhan said.
The Pune-based drug manufacturer, the Serum Institute of India, is able to initiate a preclinical trial of a vaccine conducted through the University of Oxford. The vaccine manufacturer chose 17 sites nationwide for the trial. Approximately 1,600 other people between the ages of 18 and 25 will be enrolled in the clinical trial.
Prime Minister Narendra Modi said earlier: “When scientists give us the green signal, it will occur on a scale and all arrangements have been made for it.”
There have been discussions about the “emergency authorization” of COVID-19 vaccine applicants in India.
COVID-19 vaccine: India procurement plans
Several countries, in addition to the United States and the United Kingdom, have reserved millions of doses of COVID-19 vaccines. With regard to India’s procurement plans, Vardhan said: “The Indian Medical Research Council (ICMR) is working with Bharat Biotech and has concluded a Memorandum of Understanding which obviously states that priority will be given to the provision of vaccines, if successful, to the Government of India. at a subsidized price.”
Vardahn added: “A similar agreement is being negotiated with the Serum Institute of India for 3 Covid-19 vaccine trials to be backed by ICMR. Produced through Novavax-Serum and through the Serum Institute through itself. Once the effects of Phases I and II are available, the detailed implementation plan outlines will be finalized.”
Who will receive the COVID-19 vaccine first?
“Priority will be given to health care personnel, frontline staff and vulnerable subgroups, such as other people over the age of 65 and others with chronic morbidity,” Vardhan said. “Then, depending on the amount of doses available, a special crusade will be developed and implemented to deliver vaccines to everyone,” he added.
Click here to read Mint ePaperLivemint.com is now on Telegram. Join the Livemint channel on your telegram and updated
Log in to our to save your favorites. It’ll only take a moment.
Your query has expired, reconnect.
You are now subscribed to our newsletters. If you can’t find any of our emails, check your spam folder.